{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T20:12:43Z","timestamp":1742933563590,"version":"3.40.3"},"publisher-location":"Cham","reference-count":33,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030578206"},{"type":"electronic","value":"9783030578213"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-57821-3_3","type":"book-chapter","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T09:08:43Z","timestamp":1597655323000},"page":"26-37","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SPOC: Identification of Drug Targets in Biological Networks via Set Preference Output Control"],"prefix":"10.1007","author":[{"given":"Hao","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang-Xiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,18]]},"reference":[{"key":"3_CR1","volume-title":"Network Science","author":"AL Barab\u00e1si","year":"2016","unstructured":"Barab\u00e1si, A.L., et al.: Network Science. Cambridge University Press, Cambridge (2016)"},{"issue":"1","key":"3_CR2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrg2918","volume":"12","author":"AL Barab\u00e1si","year":"2011","unstructured":"Barab\u00e1si, A.L., Gulbahce, N., Loscalzo, J.: Network medicine: a network-based approach to human disease. Nat. Rev. Genet. 12(1), 56 (2011)","journal-title":"Nat. Rev. Genet."},{"issue":"6833","key":"3_CR3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/35075138","volume":"411","author":"H Jeong","year":"2001","unstructured":"Jeong, H., Mason, S.P., Barab\u00e1si, A.L., Oltvai, Z.N.: Lethality and centrality in protein networks. Nature 411(6833), 41 (2001)","journal-title":"Nature"},{"issue":"5429","key":"3_CR4","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1126\/science.285.5429.901","volume":"285","author":"EA Winzeler","year":"1999","unstructured":"Winzeler, E.A., et al.: Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285(5429), 901\u2013906 (1999)","journal-title":"Science"},{"issue":"4","key":"3_CR5","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/bioinformatics\/btz699","volume":"36","author":"M Zeng","year":"2020","unstructured":"Zeng, M., Zhang, F., Wu, F.X., Li, Y., Wang, J., Li, M.: Protein-protein interaction site prediction through combining local and global features with deep neural networks. Bioinformatics 36(4), 1114\u20131120 (2020)","journal-title":"Bioinformatics"},{"issue":"6","key":"3_CR6","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1093\/bib\/bby088","volume":"20","author":"M Li","year":"2019","unstructured":"Li, M., Gao, H., Wang, J., Wu, F.X.: Control principles for complex biological networks. Brief. Bioinform. 20(6), 2253\u20132266 (2019)","journal-title":"Brief. Bioinform."},{"key":"3_CR7","doi-asserted-by":"crossref","unstructured":"Guo, W.F., Zhang, S.W., Zeng, T., Akutsu, T., Chen, L.: Network control principles for identifying personalized driver genes in cancer. Brief. Bioinform. (2019)","DOI":"10.1093\/bib\/bbz089"},{"issue":"7346","key":"3_CR8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nature10011","volume":"473","author":"YY Liu","year":"2011","unstructured":"Liu, Y.Y., Slotine, J.J., Barab\u00e1si, A.L.: Controllability of complex networks. Nature 473(7346), 167 (2011)","journal-title":"Nature"},{"issue":"2","key":"3_CR9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1109\/TNB.2015.2391175","volume":"14","author":"L Wu","year":"2015","unstructured":"Wu, L., Shen, Y., Li, M., Wu, F.X.: Network output controllability-based method for drug target identification. IEEE Trans. Nanobiosci. 14(2), 184\u2013191 (2015)","journal-title":"IEEE Trans. Nanobiosci."},{"key":"3_CR10","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1038\/ncomms6415","volume":"5","author":"J Gao","year":"2014","unstructured":"Gao, J., Liu, Y.Y., D\u2019souza, R.M., Barab\u00e1si, A.L.: Target control of complex networks. Nat. Commun. 5, 5415 (2014)","journal-title":"Nat. Commun."},{"issue":"3","key":"3_CR11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1049\/iet-syb.2015.0077","volume":"10","author":"L Wu","year":"2016","unstructured":"Wu, L., Li, M., Wang, J., Wu, F.X.: Minimum steering node set of complex networks and its applications to biomolecular networks. IET Syst. Biol. 10(3), 116\u2013123 (2016)","journal-title":"IET Syst. Biol."},{"issue":"11","key":"3_CR12","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/bioinformatics\/bty006","volume":"34","author":"WF Guo","year":"2018","unstructured":"Guo, W.F., et al.: Discovering personalized driver mutation profiles of single samples in cancer by network control strategy. Bioinformatics 34(11), 1893\u20131903 (2018)","journal-title":"Bioinformatics"},{"issue":"1","key":"3_CR13","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/s41467-019-10215-y","volume":"10","author":"Y Hu","year":"2019","unstructured":"Hu, Y., et al.: Optimal control nodes in disease-perturbed networks as targets for combination therapy. Nat. Commun. 10(1), 2180 (2019)","journal-title":"Nat. Commun."},{"issue":"5","key":"3_CR14","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1109\/TNB.2017.2705106","volume":"16","author":"L Wu","year":"2017","unstructured":"Wu, L., Tang, L., Li, M., Wang, J., Wu, F.X.: Biomolecular network controllability with drug binding information. IEEE Trans. Nanobiosci. 16(5), 326\u2013332 (2017)","journal-title":"IEEE Trans. Nanobiosci."},{"issue":"6","key":"3_CR15","doi-asserted-by":"crossref","first-page":"063402","DOI":"10.1088\/1742-5468\/aa6de6","volume":"2017","author":"WF Guo","year":"2017","unstructured":"Guo, W.F., et al.: Constrained target controllability of complex networks. J. Stat. Mech: Theory Exp. 2017(6), 063402 (2017)","journal-title":"J. Stat. Mech: Theory Exp."},{"issue":"7369","key":"3_CR16","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1038\/nature10543","volume":"478","author":"FJ M\u00fcller","year":"2011","unstructured":"M\u00fcller, F.J., Schuppert, A.: Few inputs can reprogram biological networks. Nature 478(7369), E4 (2011)","journal-title":"Nature"},{"key":"3_CR17","volume-title":"Linear Systems","author":"T Kailath","year":"1980","unstructured":"Kailath, T.: Linear Systems, vol. 156. Prentice-Hall, Englewood Cliffs (1980)"},{"issue":"3","key":"3_CR18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1109\/TAC.1974.1100557","volume":"19","author":"CT Lin","year":"1974","unstructured":"Lin, C.T.: Structural controllability. IEEE Trans. Autom. Control 19(3), 201\u2013208 (1974)","journal-title":"IEEE Trans. Autom. Control"},{"key":"3_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/b138283","volume-title":"Graphs, Networks and Algorithms","author":"D Jungnickel","year":"2005","unstructured":"Jungnickel, D.: Graphs, Networks and Algorithms. Springer, Heidelberg (2005). https:\/\/doi.org\/10.1007\/b138283"},{"issue":"4","key":"3_CR20","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1109\/TAES.2016.140952","volume":"52","author":"DF Crouse","year":"2016","unstructured":"Crouse, D.F.: On implementing 2D rectangular assignment algorithms. IEEE Trans. Aerosp. Electron. Syst. 52(4), 1679\u20131696 (2016)","journal-title":"IEEE Trans. Aerosp. Electron. Syst."},{"issue":"10","key":"3_CR21","doi-asserted-by":"crossref","first-page":"e1003286","DOI":"10.1371\/journal.pcbi.1003286","volume":"9","author":"L Grieco","year":"2013","unstructured":"Grieco, L., Calzone, L., Bernard-Pierrot, I., Radvanyi, F., Kahn-Perles, B., Thieffry, D.: Integrative modelling of the influence of mapk network on cancer cell fate decision. PLoS Comput. Biol. 9(10), e1003286 (2013)","journal-title":"PLoS Comput. Biol."},{"issue":"suppl\u20131","key":"3_CR22","first-page":"D901","volume":"36","author":"DS Wishart","year":"2007","unstructured":"Wishart, D.S., et al.: Drugbank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 36(suppl\u20131), D901\u2013D906 (2007)","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"3_CR23","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s10495-008-0300-z","volume":"14","author":"A Frenzel","year":"2009","unstructured":"Frenzel, A., Grespi, F., Chmelewskij, W., Villunger, A.: Bcl2 family proteins in carcinogenesis and the treatment of cancer. Apoptosis 14(4), 584\u2013596 (2009). https:\/\/doi.org\/10.1007\/s10495-008-0300-z","journal-title":"Apoptosis"},{"issue":"1","key":"3_CR24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1476-4598-12-83","volume":"12","author":"M Lafitte","year":"2013","unstructured":"Lafitte, M., et al.: FGFR3 has tumor suppressor properties in cells with epithelial phenotype. Mol. Cancer 12(1), 83 (2013)","journal-title":"Mol. Cancer"},{"issue":"1","key":"3_CR25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1878-0261.12155","volume":"12","author":"S Sigismund","year":"2018","unstructured":"Sigismund, S., Avanzato, D., Lanzetti, L.: Emerging functions of the EGFR in cancer. Mol. Oncol. 12(1), 3\u201320 (2018)","journal-title":"Mol. Oncol."},{"issue":"6","key":"3_CR26","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.humpath.2006.01.022","volume":"37","author":"MM Vleugel","year":"2006","unstructured":"Vleugel, M.M., Greijer, A.E., Bos, R., van der Wall, E., van Diest, P.J.: c-jun activation is associated with proliferation and angiogenesis in invasive breast cancer. Hum. Pathol. 37(6), 668\u2013674 (2006)","journal-title":"Hum. Pathol."},{"issue":"18","key":"3_CR27","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.2174\/092986711796011238","volume":"18","author":"C Raimondi","year":"2011","unstructured":"Raimondi, C., Falasca, M.: Targeting PDK1 in cancer. Curr. Med. Chem. 18(18), 2763\u20132769 (2011)","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"3_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41236-017-0007-6","volume":"1","author":"J G\u00f3mez Tejeda Za\u00f1udo","year":"2017","unstructured":"G\u00f3mez Tejeda Za\u00f1udo, J., Scaltriti, M., Albert, R.: A network modeling approach to elucidate drug resistance mechanisms and predict combinatorial drug treatments in breast cancer. Cancer Converg. 1(1), 1\u201325 (2017). https:\/\/doi.org\/10.1186\/s41236-017-0007-6","journal-title":"Cancer Converg."},{"key":"3_CR29","first-page":"636","volume":"8","author":"C Eischen","year":"2018","unstructured":"Eischen, C., Adams, C., Clark-Garvey, S., Porcu, P.: Targeting the Bcl-2 family in B cell lymphoma. Front. Oncol. 8, 636 (2018)","journal-title":"Front. Oncol."},{"issue":"6","key":"3_CR30","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.3892\/ijo.2013.1895","volume":"42","author":"M Zou","year":"2013","unstructured":"Zou, M., et al.: Knockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790m mutation. Int. J. Oncol. 42(6), 2094\u20132102 (2013)","journal-title":"Int. J. Oncol."},{"key":"3_CR31","doi-asserted-by":"crossref","unstructured":"Royce, M.E., Osman, D.: Everolimus in the treatment of metastatic breast cancer. Breast Cancer: Basic Clin. Res. 9, BCBCR\u2013S29268 (2015)","DOI":"10.4137\/BCBCR.S29268"},{"key":"3_CR32","doi-asserted-by":"crossref","unstructured":"Kornblum, N., et al.: Randomized phase ii trial of fulvestrant plus everolimus or placebo in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer resistant to aromatase inhibitor therapy: results of pre0102. ASCO (2018)","DOI":"10.1200\/JCO.2017.76.9331"},{"key":"3_CR33","doi-asserted-by":"crossref","unstructured":"Piha-Paul, S.A., et al.: Phase i study of the pan-HER inhibitor neratinib given in combination with everolimus, palbociclib or trametinib in advanced cancer subjects with EGFR mutation\/amplification, HER2 mutation\/amplification or HER3\/4 mutation (2018)","DOI":"10.1200\/JCO.2018.36.15_suppl.TPS2611"}],"container-title":["Lecture Notes in Computer Science","Bioinformatics Research and Applications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-57821-3_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T21:36:30Z","timestamp":1696541790000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-57821-3_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030578206","9783030578213"],"references-count":33,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-57821-3_3","relation":{},"ISSN":["0302-9743","1611-3349"],"issn-type":[{"type":"print","value":"0302-9743"},{"type":"electronic","value":"1611-3349"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"18 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"ISBRA","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"International Symposium on Bioinformatics Research and Applications","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Moscow","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Russia","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2020","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"1 December 2020","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"4 December 2020","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"16","order":9,"name":"conference_number","label":"Conference Number","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"isbra2020","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"https:\/\/isbra.confreg.org\/","order":11,"name":"conference_url","label":"Conference URL","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Single-blind","order":1,"name":"type","label":"Type","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"Easychair","order":2,"name":"conference_management_system","label":"Conference Management System","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"131","order":3,"name":"number_of_submissions_sent_for_review","label":"Number of Submissions Sent for Review","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"33","order":4,"name":"number_of_full_papers_accepted","label":"Number of Full Papers Accepted","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"18","order":5,"name":"number_of_short_papers_accepted","label":"Number of Short Papers Accepted","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"25% - The value is computed by the equation \"Number of Full Papers Accepted \/ Number of Submissions Sent for Review * 100\" and then rounded to a whole number.","order":6,"name":"acceptance_rate_of_full_papers","label":"Acceptance Rate of Full Papers","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"3","order":7,"name":"average_number_of_reviews_per_paper","label":"Average Number of Reviews per Paper","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"3","order":8,"name":"average_number_of_papers_per_reviewer","label":"Average Number of Papers per Reviewer","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"No","order":9,"name":"external_reviewers_involved","label":"External Reviewers Involved","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}}]}}